Master the SOCRA CCRP Exam with our comprehensive practice quiz. Tailored feedback, detailed explanations, and real-world scenarios to boost your confidence and success.

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


What does ICH GCP 5.18.3 state about monitoring of investigators by sponsors?

  1. Trials need not be monitored

  2. Monitoring should be minimized

  3. Trials should be adequately monitored

  4. Monitoring is the responsibility of the FDA

The correct answer is: Trials should be adequately monitored

ICH GCP 5.18.3 states that trials should be adequately monitored by sponsors, which means that sponsors are responsible for ensuring that the trials are being conducted according to proper protocols and regulations. Options A and B are incorrect because they suggest that monitoring is not necessary or should be limited, which goes against the guidelines of ICH GCP. Option D is also incorrect because while the FDA may conduct inspections and audits, it is not solely responsible for monitoring investigators in clinical trials. Overall, the correct answer highlights the importance of sponsors monitoring investigators to ensure the integrity and accuracy of clinical trial data.